Skip to main content
Equibles

Karen J. Wilson

Board Member

Elicio Therapeutics, Inc. (ELTX)
Vaxart, Inc. (VXRT)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Karen J. Wilson

Karen J. Wilson is recorded as Board Member at Elicio Therapeutics, Inc. (ELTX). Elicio Therapeutics, Inc. reported in an 8-K filed June 2, 2023 that Karen J. Wilson was appointed Class II Director, effective June 1, 2023.

“Robert R. Ruffolo, Jr., PhD, FCPP, Assaf Segal and Karen J. Wilson being appointed as Class II directors of the Company whose terms expire at the Company's 2025 annual meeting of stockholders”
Elicio Therapeutics, Inc. Form 8-K, filed June 2, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Elicio Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Leadership on record at Vaxart, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.